Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

Precise Robotically IMplanted Brain-Computer InterfacE

NCT06429735 · Neuralink Corp · Updated 9 Jan 2026

What is being tested
N1 Implant; R1 Robot
For
Tetraplegia/Tetraparesis; Quadriplegia; Cervical Spinal Cord Injury; Amyotrophic Lateral Sclerosis; Quadriplegia/Tetraplegia; Tetraplegic; Paralysis
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 22 years to 75 years. About 15 people. The full rules are on the registry page.
Where
United States (2 sites)
When
Starts or started 9 Jan 2024, ends Jan 2031. Registered 28 May 2024.
Results
None posted yet.

In the researchers' words

The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
ClinicalTrials.gov, NCT06429735

Sites

  • Barrow Neurological InstitutePhoenix, Arizona, United States
  • University of MiamiMiami, Florida, United States